Mission Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.86M Buy
27,004
+1,896
+8% +$131K 0.04% 216
2025
Q1
$1.74M Sell
25,108
-386
-2% -$26.8K 0.04% 201
2024
Q4
$2.19M Sell
25,494
-1,341
-5% -$115K 0.05% 167
2024
Q3
$3.2M Buy
26,835
+2,896
+12% +$345K 0.08% 129
2024
Q2
$3.42M Buy
23,939
+638
+3% +$91.1K 0.09% 118
2024
Q1
$2.99M Buy
23,301
+1,148
+5% +$147K 0.08% 134
2023
Q4
$2.29M Buy
22,153
+1,509
+7% +$156K 0.07% 129
2023
Q3
$1.88M Sell
20,644
-226
-1% -$20.6K 0.07% 132
2023
Q2
$1.69M Sell
20,870
-698
-3% -$56.5K 0.06% 144
2023
Q1
$1.72M Sell
21,568
-704
-3% -$56K 0.07% 141
2022
Q4
$1.51M Sell
22,272
-44
-0.2% -$2.98K 0.07% 143
2022
Q3
$1.11M Buy
22,316
+528
+2% +$26.3K 0.06% 164
2022
Q2
$1.21M Buy
21,788
+2,666
+14% +$149K 0.06% 157
2022
Q1
$1.06M Buy
19,122
+862
+5% +$47.9K 0.05% 183
2021
Q4
$1.02M Buy
18,260
+2,750
+18% +$154K 0.05% 184
2021
Q3
$745K Buy
15,510
+16
+0.1% +$769 0.04% 205
2021
Q2
$649K Sell
15,494
-182
-1% -$7.62K 0.03% 236
2021
Q1
$528K Buy
15,676
+3,504
+29% +$118K 0.03% 251
2020
Q4
$425K Buy
12,172
+4,228
+53% +$148K 0.03% 274
2020
Q3
$276K Buy
7,944
+846
+12% +$29.4K 0.02% 290
2020
Q2
$232K Buy
7,098
+132
+2% +$4.31K 0.02% 296
2020
Q1
$210K Hold
6,966
0.02% 275
2019
Q4
$202K Sell
6,966
-838
-11% -$24.3K 0.02% 328
2019
Q3
$202K Buy
+7,804
New +$202K 0.02% 305
2019
Q2
Sell
-7,864
Closed -$206K 327
2019
Q1
$206K Buy
+7,864
New +$206K 0.02% 297
2016
Q1
Sell
-6,952
Closed -$202K 164
2015
Q4
$202K Buy
+6,952
New +$202K 0.06% 133